Tusk Therapeutics Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 7

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $764M

Tusk Therapeutics General Information

Description

Developer of an innate immune system designed to harness the power of the immune system for the treatment of cancer. The company's system is developing novel immune modulating therapeutics based on an in-depth understanding of the innate immune system with a special focus on Natural Killer (NK) cell biology, enabling cancer patients to get full recovery.

Contact Information

Website
www.tusktherapeutics.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Stevenage Bioscience Catalyst
  • Gunnels Wood Road
  • Stevenage SG1 2FX
  • England, United Kingdom
Primary Industry
Biotechnology
Other Industries
Therapeutic Devices
Acquirer
Roche
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Stevenage Bioscience Catalyst
  • Gunnels Wood Road
  • Stevenage SG1 2FX
  • England, United Kingdom

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tusk Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 27-Sep-2018 $764M Completed Pre-Clinical Trials
3. Grant 14-Nov-2017 Completed Pre-Clinical Trials
2. Early Stage VC 01-Jan-2014 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Tusk Therapeutics’s complete valuation and funding history, request access »

Tusk Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an innate immune system designed to harness the power of the immune system for the treatment of cancer. The
Biotechnology
Stevenage, United Kingdom
7 As of 2018

Berlin, Germany
 

Altrincham, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tusk Therapeutics Competitors (40)

One of Tusk Therapeutics’s 40 competitors is TME Pharma, a Corporation company based in Berlin, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
TME Pharma Corporation Berlin, Germany
NeoPhore Venture Capital-Backed Altrincham, United Kingdom
Apogenix Venture Capital-Backed Heidelberg, Germany
Iovance Biotherapeutics Corporation San Carlos, CA
Mestag Therapeutics Venture Capital-Backed Cambridge, United Kingdom
You’re viewing 5 of 40 competitors. Get the full list »

Tusk Therapeutics Patents

  • 70

    Total Documents Applications and Grants

  • Total Patents Families

  • 53

    Granted

  • 7

    Pending

  • Expiring in next 12 mo

Tusk Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201804027-D0 Anti-cd25 antibody agents Inactive 13-Mar-2018
GB-201804029-D0 Anti-cd25 antibody agents Inactive 13-Mar-2018
GB-201804028-D0 Anti-cd25 antibody agents Inactive 13-Mar-2018
US-20190300613-A1 Anti-cd25 antibody agents Active 13-Mar-2018
US-20190322752-A1 Anti-cd25 antibody agents Active 13-Mar-2018 C07K16/2818
To view Tusk Therapeutics’s complete patent history, request access »

Tusk Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tusk Therapeutics Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Droia Ventures Venture Capital Minority
Innovate UK Government
Stevenage Bioscience Catalyst Accelerator/Incubator Minority
To view Tusk Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Tusk Therapeutics FAQs

  • When was Tusk Therapeutics founded?

    Tusk Therapeutics was founded in 2014.

  • Where is Tusk Therapeutics headquartered?

    Tusk Therapeutics is headquartered in Stevenage, United Kingdom.

  • What is the size of Tusk Therapeutics?

    Tusk Therapeutics has 7 total employees.

  • What industry is Tusk Therapeutics in?

    Tusk Therapeutics’s primary industry is Biotechnology.

  • Is Tusk Therapeutics a private or public company?

    Tusk Therapeutics is a Private company.

  • What is the current valuation of Tusk Therapeutics?

    The current valuation of Tusk Therapeutics is .

  • What is Tusk Therapeutics’s current revenue?

    The current revenue for Tusk Therapeutics is .

  • Who are Tusk Therapeutics’s investors?

    Droia Ventures, Innovate UK, and Stevenage Bioscience Catalyst have invested in Tusk Therapeutics.

  • Who are Tusk Therapeutics’s competitors?

    TME Pharma, NeoPhore, Apogenix, Iovance Biotherapeutics, and Mestag Therapeutics are some of the 40 competitors of Tusk Therapeutics.

  • When was Tusk Therapeutics acquired?

    Tusk Therapeutics was acquired on 27-Sep-2018.

  • Who acquired Tusk Therapeutics?

    Tusk Therapeutics was acquired by Roche.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »